Evaluating tisagenlecleucel and its potential in the treatment of relapsed or refractory diffuse large B cell lymphoma: evidence to date

Zavras PD, Wang Y, Gandhi A, Lontos K, Delgoffe GM

OncoTargets and Therapy 2019, 12:4543-4554

Published Date: 11 June 2019